PARAMETRIC PORTFOLIO ASSOCIATES LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,090,000
-28.1%
89,721
-27.9%
0.00%0.0%
Q4 2021$1,516,000
-48.2%
124,448
-34.2%
0.00%
-50.0%
Q3 2021$2,924,000
+68.0%
189,240
+55.2%
0.00%
+100.0%
Q2 2021$1,740,000
+35.1%
121,945
+105.6%
0.00%0.0%
Q1 2021$1,288,000
+63.2%
59,325
+13.7%
0.00%
Q4 2020$789,000
-26.4%
52,176
-38.1%
0.00%
-100.0%
Q3 2020$1,072,000
-25.7%
84,281
-0.2%
0.00%0.0%
Q2 2020$1,443,000
+69.6%
84,409
+31.0%
0.00%0.0%
Q1 2020$851,000
+11.1%
64,412
+35.5%
0.00%0.0%
Q4 2019$766,000
-50.2%
47,534
-43.6%
0.00%0.0%
Q3 2019$1,539,000
+114.9%
84,211
+152.8%
0.00%0.0%
Q2 2019$716,000
+11.9%
33,306
+2.1%
0.00%0.0%
Q1 2019$640,000
+37.9%
32,626
-8.6%
0.00%
Q4 2018$464,000
-42.2%
35,682
+6.4%
0.00%
-100.0%
Q3 2018$803,000
+17.2%
33,535
-6.2%
0.00%0.0%
Q2 2018$685,000
+55.7%
35,759
+0.7%
0.00%
Q1 2018$440,000
-0.7%
35,523
-1.9%
0.00%
Q4 2017$443,000
-3.5%
36,205
+8.0%
0.00%
Q3 2017$459,000
-65.0%
33,521
-60.6%
0.00%
-100.0%
Q2 2017$1,311,000
-28.0%
85,171
-13.9%
0.00%
-33.3%
Q1 2017$1,820,000
+239.6%
98,962
+71.4%
0.00%
+200.0%
Q4 2016$536,00057,7250.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders